Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal DFUs

The purpose of this study is to evaluate the efficacy of two dehydrated human umbilical cord-based medical devices, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a modified platform trial design.

Participants needed: 272
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: StimLabsUpdated: Mar 4, 2026
Eligibility criteria

At least 18 years of age or older. [+7]

Target ulcers located on the plantar aspect of the foot must be offloaded for at... [+22]

Status: Not yet recruiting

Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUs

The purpose of this study is to evaluate the efficacy of two dehydrated human umbilical cord-based medical devices, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal venous leg ulcers over 12 weeks using a modified platform trial design.

Participants needed: 272
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: StimLabsUpdated: Mar 4, 2026
Eligibility criteria

At least 18 years of age or older. [+9]

Target ulcers must be treated with compression therapy for at least 14 days prio... [+19]

Status: Recruiting

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

The purpose of this study is to evaluate the efficacy of four dehydrated complete human placental membrane, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a modified platform trial design.

Participants needed: 272
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: StimLabsUpdated: Mar 2, 2026Locations: 5
Eligibility criteria

At least 18 years of age or older. [+10]

Target ulcers located on the plantar aspect of the foot must be offloaded for at... [+23]